BTCC / BTCC Square / tipranks /
Bitwise’s Solana ETF Shatters Records - Can This Breakthrough Momentum Last?

Bitwise’s Solana ETF Shatters Records - Can This Breakthrough Momentum Last?

Author:
tipranks
Published:
2025-10-30 11:56:03
4
1

3 Best Stocks to Buy Now, 10/30/2025, According to Top Analysts

Solana's institutional adoption hits unprecedented heights as Bitwise's ETF smashes through previous benchmarks.

The Unstoppable Ascent

Bitwise's Solana-focused exchange-traded fund just demolished existing performance records, signaling a seismic shift in institutional crypto acceptance. The numbers don't lie - this isn't just another blip on the radar.

Market analysts scramble to decode whether this represents sustainable growth or another case of Wall Street discovering crypto right before the music stops.

While traditional finance veterans clutch their pearls, digital asset pioneers watch with knowing smiles. After all, when institutions finally catch up to what retail investors knew years ago, the real question becomes: are they leading or just late to the party?

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

(UDMY) – Udemy is an online learning platform that offers a wide range of courses for individuals and businesses around the world.Today, Needham analyst Ryan MacDonald maintained a Buy rating on the stock with a price target of $11 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 72.40%.

(KYTX) – Kyverna Therapeutics is a clinical-stage biotech firm developing cell therapies to treat autoimmune diseases driven by B-cells. Today, Wells Fargo analyst Derek Archila maintained a Buy rating on the stock and increased the price target to $31 from $27 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 253.3%.

(OPRA) – Bit Digital is a digital asset mining company that focuses on Bitcoin production and blockchain infrastructure. Today, TD Cowen analyst Lance Vitanza maintained a Buy rating on the stock with a price target of $33 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 75.45%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.